Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
[WEBINAR] Molecular bioanalysis considerations along the drug development journey 10 days 20 hours 52 mins 33 secs REGISTER NOW!

Key qualities to ensure success when outsourcing immunogenicity assay development

23 Oct 2019
Biomarkers Clinical Diagnostics Immunogenicity

immunogenicity-infographic-viracor

< Back to – In the Zone: Immunogenicity

 

 

 

Top content

  • Waters launches the Xevo TQ Absolute XR at ASMS 2025
  • Why NGS ELN deployments fail
  • How can diagnostic laboratories accelerate the clinical adoption of allogeneic cell therapies?

Related tags

assay CRO outsourcing Viracor Eurofins
Previous article Next article

Related articles

9 FEB 2022 JOURNAL ARTICLES

Challenges with development of a pharmacokinetics assay to measure a variably glycosylated fusion protein

7 NOV 2013 GENERAL INTEREST

PRA Staff Named Finalists in Clinical Researcher of the Year Competition

21 OCT 2015 GENERAL INTEREST

Press release: Quintiles named 2015 Frost & Sullivan Asia Pacific CRO company of the year

15 JUL 2014 JOURNAL ARTICLES

Application of the Gyrolab platform to ligand-binding assays: a user’s perspective

12 JUL 2013 LBA

Call for papers: Matrix effects in the bioanalysis of large molecules by ligand-binding assaysCall for papers: Matrix effects in the bioanalysis of large molecules by ligand-binding assays

5 SEP 2016 NEWS

Blood test may be able to detect biomarkers as predictor of Alzheimer’s disease

  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
Contact
Contact Us
Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone